The Meningitis Vaccine Project (MVP), a collaboration between PATH and the World Health Organization, works to eliminate epidemic meningitis as a public health problem in sub-Saharan Africa. The MVP website includes information on …

MVP News Digest provides a quarterly update of activities at the Meningitis Vaccine Project (MVP), a partnership between the World Health Organization and PATH. MVP works to eliminate epidemic meningitis as a public health problem in sub-Saharan …

This article, published in The Lancet Infectious Diseases, reviews published studies of meningococcal carriage in the African meningitis belt in order to better understand the potential impact of meningococcal conjugate vaccines. The review …

This article, published in Annals of Tropical Medicine and Parasitology, discusses the different serotypes of meningococcus that cause disease in Africa, including group-A meningococci, which cause meningococcal epidemics in the African Meningitis …

This article, published in Expert Review of Vaccines, summarizes the existing data on Neisseria meningitidis W135 epidemiology, immunology, and vaccines as they relate to meningitis in sub-Saharan Africa. Public health approaches to meningitis …

The authors of this article, published in Epidemiology and Infection, analyzed cerebrospinal fluid samples during the 2009 meningitis season in Niger, the largest epidemic observed in Niger since those of  to 1996 …

The authors of this article, published in Epidemiology and Infection, used deterministic compartmental models to investigate how well simple model structures with seasonal forcing were able to qualitatively capture patterns of meningococcal …

This article, published in the journal Vaccine, reviews the data of meningococcal strains recovered from outbreaks and epidemics in the African meningitis belt, which can provides important insights on the biology and epidemiology of this pathogen. …

In Niger, the introduction campaign of MenAfriVac™, a new conjugate vaccine against Neisseria meningitidis serogroup A, was conducted in the District of Filingue, during September 2010. The authors of this article, published in …

This report summarizes the design and key findings of temperature monitoring studies that gathered ambient temperature data during different HPV vaccine delivery strategies and in multiple geographic settings and seasons.

This report discusses a five-year human papillomavirus (HPV) vaccine demonstration project in Uganda that aims to demonstrate how existing health systems can be adapted to successfully provide HPV vaccine to young adolescent girls. HPV vaccine …

As part of the project Optimize traveling exhibit, this banner illustrates the concept of integrating vaccines with other health products in streamlined supply chains. It highlights Senegal’s “moving warehouse,” which was …

This article, featured in Science in Africa, outlines the burden of meningoccoal disease in Africa and discusses various projects to develop a new meningococcal vaccine for Africa that can provide long-term protection across all age groups and that …

This infographic highlights key interventions that can help Nigeria scale up its immunization coverage and save children's lives.

This report presents the results of demonstration projects and other activities undertaken in Senegal from 2009 to 2012 as part of a partnership between project Optimize and the Senegalese Ministry of Health. The activities aimed to demonstrate …

This report presents the results and findings of three demonstration projects undertaken in Tunisia as part of a partnership between project Optimize and the Tunisian Ministry of Health. Between 2009 and 2012, the partnership aimed to demonstrate …

This article, which appeared in the American Journal of Tropical Medicine and Hygiene, describes a cross-sectional study conducted in Kenya’s Nyanza Province to investigate the burden of viral respiratory disease, including influenza, in …

More and more countries are engaging the private sector in vaccine supply chain and logistic functions. As a part of this review, a case study was conducted in the Western Cape of South Africa whereby the Biovac Institute (a third-party, …

This article, published in Influenza and Other Respiratory Viruses, reviews published data on pandemic influenza virus infection in Africa from January 1950 through August 2008, a time period covering the influenza A(H2N2) pandemic of 1957 and the …

This article, published in Morbidity and Mortality Weekly Report, analyzes data for 2002 to 2008 from the Pediatric Bacterial Meningitis (PBM) Surveillance Network, which collects information on laboratory-confirmed bacterial meningitis cases among …

This article, published in the New England Journal of Medicine (NEJM), reports results from a pivotal, large-scale Phase 3 trial of RTS,S/AS01 malaria vaccine. When compared to immunization with a control vaccine, infants (aged 6 to 12 weeks at …

The Pneumonia Etiology Research for Child Health (PERCH) study will characterize the etiologic distribution of pathogens that are causing severe pneumonia among children under five years of age who have been hospitalized for their illness in seven …

This analysis, published in The Open Vaccine Journal, describes the policy environment related to human papillomavirus (HPV) vaccine introduction, identifies the policy processes and key stakeholders in HPV vaccine introduction, summarizes specific …

In this five-minute video, scientist-advocates describe their critical role in closing the gap between the availability of lifesaving interventions and developing countries' access to them. A malaria vaccine could be available in just a few short …

This article, published in The British Medical Journal, describes a study of secondary meningococcal disease infection in which researchers used either meningococcal or tetanus toxoid vaccine to immunize household contacts of patients with …